Latest news with #WolfHaldenstein
Associated Press
23-05-2025
- Business
- Associated Press
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a distinguished law firm with over 125 years of history, announces it is investigating claims on behalf of investors of P3 Health Partners, Inc. (NASDAQ: PIII) ('P3' or the 'Company'). (NASDAQ: PIII) Allegations and Investigation Focus: Triggering Events: 1. November 12, 2024 – P3 reported disappointing financial results in its Form 10-Q filed with the United States Securities and Exchange Commission (SEC): 2. March 28, 2025 – Annual Form 10-K disclosed: Why Wolf Haldenstein Adler Freeman & Herz LLP? This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors. We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP. Contact Information: Firm: Wolf Haldenstein Adler Freeman & Herz LLP Primary Contact: Gregory Stone, Director of Case and Financial Analysis Email: [email protected] or [email protected] Phone: (800) 575-0735 or (212) 545-4774 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Associated Press
16-05-2025
- Business
- Associated Press
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). Key Details: Contact Information Firm: Wolf Haldenstein Adler Freeman & Herz LLP Primary Contact: Gregory Stone, Director of Case and Financial Analysis Email: mailto:[email protected] or [email protected] Phone: (800) 575-0735 or (212) 545-4774 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Associated Press
13-03-2025
- Business
- Associated Press
Wolf Haldenstein Adler Freeman & Herz LLP is investigating DoubleVerify Holdings Inc. for potential violations of securities laws
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DoubleVerify Holdings Inc.. (NYSE: DV) ('DoubleVerify' or the 'Company'). The investigation concerns whether DoubleVerify Holdings Inc. and certain of its officers and/or directors have engaged in securities fraud. On May 7, 2024, the Company announced its financial results for the first quarter of 2024, noting that it was adjusting its 'full-year 2024 guidance ranges to 17% revenue growth and 31% adjusted EBIITDA margins at the midpoints primarily due to uneven spending patterns among select large advertisers.' On this news, the Company's shares declined from a prior day's close of $30.57 per share down to $18.78 per share on May 8, 2024. On February 28, 2025, DoubleVerify reported fourth quarter earnings and provided guidance for fiscal 2025 including a projection of 10% growth, which continues a multi-year growth rate decline. On this news, the Company's stock price declined from the prior day's closing price of $21.93 per share down to $13.90 per share to close February 28, 2025. Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation. If you wish to discuss this investigation or have any questions regarding your rights and interests, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at [email protected]. Wolf Haldenstein Adler Freeman & Herz LLP This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Associated Press
05-03-2025
- Business
- Associated Press
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating MediaAlpha Inc. for potential violations of securities laws
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MediaAlpha Inc. (NYSE: MAX).('MediaAlpha' or the 'Company'). The investigation concerns whether MediaAlpha and certain of its officers and/or directors have engaged in securities fraud. MediaAlpha aims to help insurance carriers and distributors target and acquire consumers more efficiently and at greater scale through technology and data science. The Company's technology platform brings together leading insurance carriers and high-intent consumers through a real-time, programmatic, transparent, and results-driven ecosystem. MediaAlpha claims to be the largest online customer acquisition platform in the core verticals of property & casualty insurance, health insurance and life insurance. On November 4, 2024, MediaAlpha disclosed receipt of a letter from the FTC, which stated that the FTC was 'prepared to recommend the filing of a complaint against the Company' claiming that MediaAlpha falsely 'represented itself as affiliated with government entities, made misleading claims (in particular regarding health insurance products and use of consumers' personal information) and utilized deceptive advertising.' On this news, MediaAlpha's stock declined $4.46 per share or 27.7% to close at $11.62 per share. Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation. Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at [email protected]. Contact: Wolf Haldenstein Adler Freeman & Herz LLP This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Associated Press
04-03-2025
- Automotive
- Associated Press
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Avis Budget Group, Inc. for potential violations of securities laws
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ('ABG') (NASDAQ: CAR). The investigation concerns whether Avis Budget Group, Inc. and certain of its officers and/or directors have engaged in securities fraud. ABG is a leading global provider of mobility solutions through multiple. recognized brands including Avis, Budget, and Zipcar. Through its brands, ABG offers a range of options from car and truck rental to car sharing. On February 11, 2025, ABG released its financial results for Q4 and the full year 2024. Therein, the Company reported a loss of $55.66 per share in Q4 versus a profit of $7.10 in Q4 2023. Management attributed the loss to a change in strategy to accelerate fleet rotations, which resulted in shortening the life of most vehicles in the Americas' segment, as well as one-time impairment charge. The Company also announced that its CEO would transition from that role to a 'Board Advisor' effective June 30, 2025. On this news, ABG shares declined by 6.82%. In the prior quarter's earnings call, management repeatedly referenced that the Company's '25 fleet buy was near completion without mention of a potential impairment or write-down associated with rotation of the fleet. In fact, management repeatedly stated that they were optimizing the fleet to meet demand. With respect to the impact of the '25 buy on earnings, management stated that they would 'have more to say about the impact our model year '25 buy will have on our earnings' during the 'year-end call[.]' Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation. If you wish to discuss this investigation or have any questions regarding your rights and interests, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at [email protected]. Contact: Wolf Haldenstein Adler Freeman & Herz LLP This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
